Nuwellis, Inc. Files 8-K

Ticker: NUWE · Form: 8-K · Filed: Sep 30, 2025 · CIK: 1506492

Nuwellis, Inc. 8-K Filing Summary
FieldDetail
CompanyNuwellis, Inc. (NUWE)
Form Type8-K
Filed DateSep 30, 2025
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, regulatory-filing

TL;DR

Nuwellis filed a routine 8-K, no major news.

AI Summary

Nuwellis, Inc. filed an 8-K on September 30, 2025, reporting other events. The company, formerly known as CHF Solutions, Inc. and Sunshine Heart, Inc., is based in Eden Prairie, MN, and operates in the electromedical apparatus industry. The filing does not disclose specific financial transactions or material events beyond its routine reporting nature.

Why It Matters

This 8-K filing indicates Nuwellis, Inc. is making a regulatory submission, but it does not contain information about significant new developments or financial changes for investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report and does not indicate any new risks or material changes.

Key Players & Entities

  • Nuwellis, Inc. (company) — Registrant
  • September 30, 2025 (date) — Date of Report
  • Eden Prairie, MN (location) — Principal Executive Offices
  • CHF Solutions, Inc. (company) — Former Company Name
  • Sunshine Heart, Inc. (company) — Former Company Name

FAQ

What is the primary business of Nuwellis, Inc.?

Nuwellis, Inc. operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry, SIC code 3845.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on September 30, 2025.

What is the principal executive office address for Nuwellis, Inc.?

The principal executive offices are located at 12988 Valley View Road, Eden Prairie, MN 55344.

Has Nuwellis, Inc. operated under any previous names?

Yes, Nuwellis, Inc. was formerly known as CHF Solutions, Inc. (name change effective 20170523) and Sunshine Heart, Inc. (name change effective 20101124).

What is the SEC file number for Nuwellis, Inc.?

The SEC file number for Nuwellis, Inc. is 001-35312.

Filing Stats: 395 words · 2 min read · ~1 pages · Grade level 10.7 · Accepted 2025-09-30 08:55:19

Key Financial Figures

  • $0.0001 — ich registered Common Stock, par value $0.0001 per share NUWE Nasdaq Capital Marke

Filing Documents

01

Item 8.01. Other Events. On September 30, 2025, Nuwellis, Inc. announced findings from the ULTRA-Peds registry, a multi-center observational study examining the real-world use of the Aquadex System in children with acute kidney injury (AKI), fluid overload, or congenital kidney failure.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 30, 2025 NUWELLIS, INC. By: /s/ John L. Erb Name: John L. Erb Title: President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.